Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Sales, net	$ 12,326	$ 12,751
Cost of sales	11,329	11,327
Gross profit	997	1,424
Selling and administrative expenses	967	839
Operating income	30	585
Other income (expense), net:
Interest expense	(13)	(32)
Unrealized loss on investment in iBio Stock	(4)	(20)
Other income, net	3	6
Total other expense, net	(14)	(46)
Income before income taxes	16	539
Income tax expense, net	51	23
Net (loss) income	$ (35)	$ 516
Basic net income per common share (in dollars per share)	$ (0.00)	$ 0.02
Diluted net income per common share (in dollars per share)	$ (0.00)	$ 0.02
Weighted average common shares outstanding - basic (in shares)	29,949,610	29,817,919
Add: Equivalent shares outstanding - Stock Options (in shares)	0	2,781,977
Weighted average common shares outstanding - diluted (in shares)	29,949,610	32,599,896